Jul 2019 $3 M Private placement after listing $2 to $10 million 1
Bio Key International Inc.: Private sale, Jul 2019 × Investors in this round 1 investor had bought by the notice of Jul 25, 2019: 1 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 2 investors are named for Bio Key International Inc. as a whole in other filings: see Investors below.
What the notice says
Amount sold $3 M of $3 M offered
Smallest investment taken no minimum stated
What was sold debt, options or other rights to buy securities Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions $178,500
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Cecilia K. Welch · Executive Officer Michael W. DePasquale · Executive Officer, Director Mira K. LaCous · Executive Officer Fabian E. Shin · Director Pieter E. Knook · Director Robert J. Michel · Director Thomas E. Bush · Director Thomas E. Gilley · Director Wong Kwok W. Fong · Director Yan E. Jianhui · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round Maxim Group LLC (CRD 120708) · broker-dealer Maxim Group LLC (CRD 120708) · New York, New York Sold in NY Signed by Cecilia Welch, Cfo. Newest notice filed Jul 25, 2019. Read the notice at the SEC .
debt, options SEC Nov 2014 $1 M Private placement after listing Under $2 million 20
Bio Key International Inc.: Private sale, Nov 2014 × Investors in this round 20 investors had bought by the notice of Nov 19, 2014: 20 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 2 investors are named for Bio Key International Inc. as a whole in other filings: see Investors below.
What the notice says
Amount sold $1 M of $2 M offered; $0 M still to sell
Smallest investment taken no minimum stated
What was sold equity, options or other rights to buy securities Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks payments to its own people as estimates
The company Corporation, incorporated in Delaware People named in the notice Cecilia E. Welch · Executive Officer Michael W. DePasquale · Executive Officer, Director Mira K. LaCous · Executive Officer Renat K. Zhdanov · Executive Officer Scott K. Mahnken · Executive Officer Barbara P. Rivera · Director Charles P. Romeo · Director John P. Schoenherr · Director Thomas E. Bush, III · Director Thomas E. Gilley · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Cecilia Welch, Chief Financial Officer. Newest notice filed Nov 19, 2014. Read the notice at the SEC .
equity, options SEC Oct 2013 $4 M Private placement after listing $2 to $10 million 47
Bio Key International Inc.: Private sale, Oct 2013 × Investors in this round 47 investors had bought by the notice of Nov 8, 2013: 47 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 2 investors are named for Bio Key International Inc. as a whole in other filings: see Investors below.
What the notice says
Amount sold $4 M of $4 M offered; $0 M still to sell
Smallest investment taken $100,000
What was sold equity, options or other rights to buy securities Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions $295,768
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks sales commissions as estimates
The company Corporation, incorporated in Delaware People named in the notice Cecilia Welch · Executive Officer Renat Zhdanov · Executive Officer Scott Mahnken · Executive Officer Charles Romeo · Director John Schoenherr · Director Michael DePasquale · Director Thomas Colatosti · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round Dougherty & Company LLC (CRD 7477) · Minneapolis, Minnesota Sold in CA, CO, IL, MA, MD, NJ, NY, PA, SD, WI Signed by Cecilia Welch, Chief Financial Officer. Newest notice filed Nov 8, 2013. Read the notice at the SEC .
equity, options SEC Jul 2013 $1 M Private placement after listing Under $2 million 15
Bio Key International Inc.: Private sale, Jul 2013 × Investors in this round 15 investors had bought by the notice of Aug 6, 2013: 15 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 2 investors are named for Bio Key International Inc. as a whole in other filings: see Investors below.
What the notice says
Amount sold $1 M of $1 M offered
Smallest investment taken no minimum stated
What was sold equity, options or other rights to buy securities
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Cecilia C. Welch · Executive Officer Michael W. DePasquale · Executive Officer, Director Mira K LaCous · Executive Officer Renat K Zhdanov · Executive Officer Scott K Mahnken · Executive Officer Charles P. Romeo · Director Jeffrey J. May · Director John P. Schoenherr · Director Thomas J. Colatosti · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Cecilia C. Welch, Chief Financial Officer. Newest notice filed Aug 6, 2013. Read the notice at the SEC .
equity, options SEC Dec 2009 $2 M Issued in a merger or acquisition $2 to $10 million 1
Bio Key International Inc.: Private sale, Dec 2009 × Investors in this round 1 investor had bought by the notice of Dec 23, 2009: 1 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 2 investors are named for Bio Key International Inc. as a whole in other filings: see Investors below.
What the notice says
Amount sold $2 M of $2 M offered
Smallest investment taken no minimum stated
What was sold options or other rights to buy securities
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Kenneth S. Souza · Executive Officer Michael W. DePasquale · Executive Officer, Director Randy P. Fodero · Executive Officer Thomas Colatosti · Executive Officer, Director Charles P. Romeo · Director Jeffrey J. May · Director John P. Schoenherr · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Thomas J. Colatosti, Ceo. Newest notice filed Dec 23, 2009. Read the notice at the SEC .
options SEC